Fidia Farmaceutici SPA | Hylagan | Which Medical Device
From Which Medical Device
Hyalgan(R) was the first viscosupplement approved by the FDA in 1997. It contains a high molecular weight fraction of purified natural sodium hyaluronate, extracted from rooster combs. It comes in a 5-injection regimen given weekly providing pain relief for up to 6 months. Some patients benefit from the first three injections given at weekly intervals.
The preparation has not been found to interfere with any other medication for osteoarthritis or any other medical condition. It has also been proven safe for repeat treatment if needed.
It is contraindicated in patients with hypersensitivity to hyaluronic acid preparations. Intra-articular injections are contraindicated in cases of already infected skin or in presence of skin disease at the injection site to reduce the potential for developing septic arthritis. Patients are encouraged to avoid any strenuous or prolonged activities involving their hands for the first 48 hours after the intra-articular injection.
Your opinion matters to others - rate this device or add a comment
Did you know you can Register for FREE with this website?
Registration gives you full access to all of the features of WhichMedicalDevice. Find out more ...
WhichMedicalDevice is a FREE resource created by clinicians for clinicians.
Registration is free and gives you unlimited access to all of the content and features of this website.
Find out more...Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...
Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.
We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.
